Cotinga Pharmaceuticals Inc COTQF

Healthcare Biotechnology

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.

GREY:COTQF - Post by User

Cotinga Pharmaceuticals Inc

Bullboard Posts

Post by Sandalson Jul 04, 2000 12:58pm

224 Views

Post# 2151304

Looking good...

Now have 42000 on the bid at 0.52, 100000 on the bid at 0.51. Sellers are also moving their asks up slowly as the bids come in. All contributing to a nice healthy, controlled move upwards. Should see 0.60 today.

Bullboard Posts

Barrick Gold employees detained in Mali amid ongoing dispute